Trial 5C-11-2


Phase II Clinical Trial of Eribulin in Advanced or Recurrent Cervical Cancer.

Type: Treatment
Phase: Phase II
Status: Not Open (Closed)
Treatments: Chemotherapy: Systemic
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Lynda Roman, M.D.
Other Trial Staff:  Grace Facio, R.N., Marissa Aldana, D.M., Stacie DeFilio, Coordinator, Kristy Watkins, R.N.

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3300.